BusinessLegalPipelineResearchEventsProducts
Browse All Stories »
FEATURED
FDA issues company response letter to Astellas for IZERVAY supplemental NDA

FDA issues company response letter to Astellas for IZERVAY supplemental NDA

Agency rejects proposal for positive 24-month data to be included in prescribing information; clarifies no issue with safety and benefit/risk of use.

Earn FREE CE 24/7 with Courses by Eyes On Eyecare

Check it out

Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.

TRENDING
Videos
EyeMD EMR's patient engagement system targets workflow efficiency
EyeMD EMR's patient engagement system targets workflow efficiency
Optase's Allegro Eye Drops target environmental irritant relief
Optase's Allegro Eye Drops target environmental irritant relief
Lumenis's OptiPLUS delivers clinically significant results for DED
Lumenis's OptiPLUS delivers clinically significant results for DED
Ophthalmology Tech Forum to showcase groundbreaking industry innovations
Ophthalmology Tech Forum to showcase groundbreaking industry innovations
Watch More
Business
Harrow launches initiative for expanded access, price cuts of branded products
Harrow launches initiative for expanded access, price cuts of branded products
Harrow partners with Asembia for expanded branded ophthalmic product access
Harrow partners with Asembia for expanded branded ophthalmic product access
AlloVir and Kalaris to form retinal disease-focused company
AlloVir and Kalaris to form retinal disease-focused company
Tarsus names Elizabeth Yeu, MD, as new chief medical officer
Tarsus names Elizabeth Yeu, MD, as new chief medical officer
Research
Could optic disc hemorrhage impact glaucoma progression?
Could optic disc hemorrhage impact glaucoma progression?
Could RNFL changes and vessel density detect pseudoexfoliation glaucoma?
Could RNFL changes and vessel density detect pseudoexfoliation glaucoma?
New prediction model proposed for eyelid sebaceous carcinoma
New prediction model proposed for eyelid sebaceous carcinoma
Omnibus model identifies framework for effective myopia management
Omnibus model identifies framework for effective myopia management
Pipeline
Eyenovia's phase 3 pediatric myopia trial fails primary goal
Eyenovia's phase 3 pediatric myopia trial fails primary goal
PolyActiva reports positive phase 1b/2a data on biodegradable glaucoma implant
PolyActiva reports positive phase 1b/2a data on biodegradable glaucoma implant
FDA accepts Aldeyra's reproxalap DED NDA resubmission
FDA accepts Aldeyra's reproxalap DED NDA resubmission
Atsena and Nippon Shinyaku to collaborate on LCA1 gene therapy in US
Atsena and Nippon Shinyaku to collaborate on LCA1 gene therapy in US
Products
FDA issues company response letter to Astellas for IZERVAY supplemental NDA
FDA issues company response letter to Astellas for IZERVAY supplemental NDA
Konan Medical launches objectiveFIELD visual field analyzer
Konan Medical launches objectiveFIELD visual field analyzer
EssilorLuxottica's Nuance Audio pairs sight and sound
EssilorLuxottica's Nuance Audio pairs sight and sound
eSight showcases wearable assistive device for central vision loss
eSight showcases wearable assistive device for central vision loss
Legal
FTC refunds over $1M to bait-and-switch LASIKPlus consumers
FTC refunds over $1M to bait-and-switch LASIKPlus consumers
Updated Eyeglass Rule officially takes effect
Updated Eyeglass Rule officially takes effect
FTC supports proposed FDA interchangeable biosimilar drug guidance
FTC supports proposed FDA interchangeable biosimilar drug guidance
LumiThera receives first CPT code for retina-based PBM therapy
LumiThera receives first CPT code for retina-based PBM therapy
Archives
Hello 2023 — Weekly Glance
Hello 2023 — Weekly Glance
Can we treat uveitis without steroids? — Weekly Glance
Can we treat uveitis without steroids? — Weekly Glance
Can I have one dilation drop instead of two? — Weekly Glance
Can I have one dilation drop instead of two? — Weekly Glance
Are those dilation reversal drops available yet? — Weekly Glance
Are those dilation reversal drops available yet? — Weekly Glance
Events
AOAExcel to host financial wellness workshop for optometrists
AOAExcel to host financial wellness workshop for optometrists
Foundation Fighting Blindness to host webinar on IRDs, low vision
Foundation Fighting Blindness to host webinar on IRDs, low vision
Eyes On Retina 2024 features hot topics and global attendees
Eyes On Retina 2024 features hot topics and global attendees
Registration for Eyes On 2025 is now open
Registration for Eyes On 2025 is now open
Browse All Stories »